Holdings (Monthly)
Guide ↗
Biotechnology Fund
· Rydex Variable Trust| # | Name | Ticker | Since | Shares | Value | % Port | Cat |
|---|---|---|---|---|---|---|---|
| 1 | AbbVie Inc. | ABBV | Mar 2026 | 3,661 | $796K | 7.46% | EC |
| 2 | Amgen Inc. | AMGN | Mar 2026 | 1,602 | $564K | 5.28% | EC |
| 3 | Gilead Sciences Inc. | GILD | Mar 2026 | 3,830 | $534K | 5.00% | EC |
| 4 | Vertex Pharmaceuticals Incorporated | VRTX | Mar 2026 | 966 | $431K | 4.04% | EC |
| 5 | Regeneron Pharmaceuticals, Inc. | REGN | Mar 2026 | 496 | $383K | 3.59% | EC |
| 6 | Alnylam Pharmaceuticals Inc. | ALNY | Mar 2026 | 848 | $281K | 2.63% | EC |
| 7 | Insmed Inc | INSM | Mar 2026 | 1,616 | $264K | 2.48% | EC |
| 8 | BEONE MEDICINES LTD | ONC | Mar 2026 | 829 | $246K | 2.31% | EC |
| 9 | NATERA INC | NTRA | Mar 2026 | 1,128 | $226K | 2.11% | EC |
| 10 | United Therapeutics Corporation | UTHR | Mar 2026 | 376 | $223K | 2.09% | EC |
| 11 | Biogen Inc | BIIB | Mar 2026 | 1,180 | $216K | 2.03% | EC |
| 12 | Royalty Pharma PLC | RPRX | Mar 2026 | 4,443 | $213K | 2.00% | EC |
| 13 | Illumina Inc | ILMN | Mar 2026 | 1,519 | $187K | 1.75% | EC |
| 14 | Revolution Medicines Inc | RVMD | Mar 2026 | 1,871 | $182K | 1.71% | EC |
| 15 | Moderna Inc | MRNA | Mar 2026 | 3,493 | $177K | 1.66% | EC |
| 16 | AstraZeneca PLC | AZN | Mar 2026 | 875 | $173K | 1.62% | EC |
| 17 | Argenx SE | ARGX | Mar 2026 | 236 | $172K | 1.62% | EC |
| 18 | Incyte Corporation. | INCY | Mar 2026 | 1,779 | $167K | 1.57% | EC |
| 19 | Viatris Inc | VTRS | Mar 2026 | 11,963 | $162K | 1.51% | EC |
| 20 | Bridgebio Pharma Inc | BBIO | Mar 2026 | 2,134 | $158K | 1.49% | EC |
| 21 | Alkermes PLC | ALKS | Mar 2026 | 4,470 | $158K | 1.48% | EC |
| 22 | Jazz Pharmaceuticals PLC | JAZZ | Mar 2026 | 833 | $157K | 1.48% | EC |
| 23 | Neurocrine Biosciences Inc | NBIX | Mar 2026 | 1,158 | $153K | 1.43% | EC |
| 24 | Guardant Health Inc | GH | Mar 2026 | 1,643 | $152K | 1.42% | EC |
| 25 | Roivant Sciences Ltd | ROIV | Mar 2026 | 5,450 | $151K | 1.41% | EC |
| 26 | Ionis Pharmaceuticals, Inc. | IONS | Mar 2026 | 1,983 | $149K | 1.40% | EC |
| 27 | Exelixis, Inc. | EXEL | Mar 2026 | 3,237 | $139K | 1.30% | EC |
| 28 | Medpace Holdings Inc. | MEDP | Mar 2026 | 282 | $135K | 1.27% | EC |
| 29 | Biomarin Pharmaceutical Inc. | BMRN | Mar 2026 | 2,371 | $134K | 1.26% | EC |
| 30 | Apellis Pharmaceuticals Inc | APLS | Mar 2026 | 3,277 | $132K | 1.24% | EC |
| 31 | Arrowhead Pharmaceuticals Inc | ARWR | Mar 2026 | 2,102 | $132K | 1.24% | EC |
| 32 | Cytokinetics Inc | CYTK | Mar 2026 | 1,921 | $127K | 1.19% | EC |
| 33 | Vaxcyte Inc | PCVX | Mar 2026 | 2,103 | $122K | 1.15% | EC |
| 34 | CRISPR Therapeutics AG | CRSP | Mar 2026 | 2,555 | $122K | 1.14% | EC |
| 35 | Halozyme Therapeutics Inc | HALO | Mar 2026 | 1,811 | $117K | 1.10% | EC |
| 36 | BioNTech SE | BNTX | Mar 2026 | 1,288 | $114K | 1.07% | EC |
| 37 | Axsome Therapeutics Inc. | AXSM | Mar 2026 | 651 | $110K | 1.03% | EC |
| 38 | Ascendis Pharma A/S | ASND | Mar 2026 | 476 | $109K | 1.02% | EC |
| 39 | COGENT BIOSCIENCES INC | COGT | Mar 2026 | 2,770 | $107K | 1.00% | EC |
| 40 | Arcellx Inc | ACLX | Mar 2026 | 928 | $107K | 1.00% | EC |
| 41 | TG Therapeutics Inc | TGTX | Mar 2026 | 3,127 | $104K | 0.97% | EC |
| 42 | PTC Therapeutics, Inc. | PTCT | Mar 2026 | 1,509 | $103K | 0.96% | EC |
| 43 | Scholar Rock Holding Corp. | SRRK | Mar 2026 | 2,063 | $101K | 0.95% | EC |
| 44 | Madrigal Pharmaceuticals Inc | MDGL | Mar 2026 | 186 | $97K | 0.91% | EC |
| 45 | Mirum Pharmaceuticals Inc. | MIRM | Mar 2026 | 1,043 | $96K | 0.90% | EC |
| 46 | Protagonist Therapeutics Inc | PTGX | Mar 2026 | 893 | $94K | 0.88% | EC |
| 47 | Amicus Therapeutics Inc. | FOLD | Mar 2026 | 6,081 | $88K | 0.82% | EC |
| 48 | Rhythm Pharmaceuticals Inc | RYTM | Mar 2026 | 969 | $84K | 0.79% | EC |
| 49 | APOGEE THERAPEUTICS INC | APGE | Mar 2026 | 962 | $81K | 0.76% | EC |
| 50 | Kymera Therapeutics Inc | KYMR | Mar 2026 | 929 | $77K | 0.73% | EC |
| 51 | Twist Bioscience Corporation | TWST | Mar 2026 | 1,599 | $76K | 0.71% | EC |
| 52 | Viking Therapeutics Inc. | VKTX | Mar 2026 | 2,334 | $76K | 0.71% | EC |
| 53 | SUMMIT THERAPEUTICS INC | SMMT | Mar 2026 | 3,923 | $74K | 0.70% | EC |
| 54 | Nuvalent Inc | NUVL | Mar 2026 | 722 | $74K | 0.69% | EC |
| 55 | Acadia Pharmaceuticals Inc | ACAD | Mar 2026 | 3,242 | $72K | 0.68% | EC |
| 56 | Travere Therapeutics Inc | TVTX | Mar 2026 | 2,412 | $72K | 0.67% | EC |
| 57 | Sarepta Therapeutics Inc | SRPT | Mar 2026 | 3,207 | $70K | 0.65% | EC |
| 58 | Celcuity Inc. | CELC | Mar 2026 | 611 | $70K | 0.65% | EC |
| 59 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | Mar 2026 | 2,943 | $69K | 0.65% | EC |
| 60 | Veracyte Inc | VCYT | Mar 2026 | 2,127 | $69K | 0.64% | EC |
| 61 | LIQUIDIA CORP | LQDA | Mar 2026 | 1,765 | $67K | 0.62% | EC |
| 62 | BEAM THERAPEUTICS INC | BEAM | Mar 2026 | 2,543 | $61K | 0.57% | EC |
| 63 | Ultragenyx Pharmaceuticals Inc | RARE | Mar 2026 | 2,714 | $57K | 0.53% | EC |
| 64 | Praxis Precision Medicines Inc | PRAX | Mar 2026 | 167 | $54K | 0.50% | EC |
| 65 | GRAIL Inc | GRAL | Mar 2026 | 1,023 | $53K | 0.50% | EC |
| 66 | Soleno Therapeutics Inc | SLNO | Mar 2026 | 1,567 | $52K | 0.49% | EC |
| 67 | Recursion Pharmaceuticals Inc | RXRX | Mar 2026 | 16,655 | $51K | 0.48% | EC |
| 68 | Krystal Biotech Inc | KRYS | Mar 2026 | 197 | $51K | 0.48% | EC |
| 69 | Intellia Therapeutics Inc | NTLA | Mar 2026 | 3,943 | $51K | 0.47% | EC |
| 70 | LEGEND BIOTECH CORP | LEGN | Mar 2026 | 2,794 | $51K | 0.47% | EC |
| 71 | Adma Biologics Inc | ADMA | Mar 2026 | 5,232 | $47K | 0.44% | EC |
| 72 | J.P. MORGAN SECURITIES LLC | 000000000 | Mar 2026 | 26,922 | $27K | 0.25% | RA |
| 73 | MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED | 000000000 | Mar 2026 | 24,466 | $24K | 0.23% | RA |
| 74 | Akero Therapeutics Inc | AKRO | Mar 2026 | 1,848 | $0 | 0.00% | EC |
| 75 | SANOFI SA - CVR | 000000000 | Mar 2026 | 940 | $0 | 0.00% | EC |